Similar articles

• The evaluation of present antileprosy compounds.

  Browne SG. Browne SG. Adv Pharmacol Chemother. 1969;7:211-51. Adv Pharmacol Chemother. 1969. PMID: 4910168 Review. No abstract available.
• Antileprosy drugs.

  [No authors listed] [No authors listed] Br Med J. 1971 Jul 17;3(5767):174-6. Br Med J. 1971. PMID: 4104273 Free PMC article. No abstract available.
• Comments on the chemotherapy of leprosy as influenced by present knowledge of Mycobacterium leprae.

  Pattyn SR. Pattyn SR. Lepr Rev. 1973 Sep;43(3):126-36. doi: 10.5935/0305-7518.19720018. Lepr Rev. 1973. PMID: 4120832 Review. No abstract available.
• Studies on sulfone resistance in leprosy. 3. A case of "partial" resistance.

  Pearson JM, Pettit JH, Rees RJ. Pearson JM, et al. Int J Lepr Other Mycobact Dis. 1968 Apr-Jun;36(2):171-8. Int J Lepr Other Mycobact Dis. 1968. PMID: 4877115 No abstract available.
• Drug resistance of Mycobacterium leprae, particularly to DDS.

  Rees RJ. Rees RJ. Int J Lepr Other Mycobact Dis. 1967 Oct-Dec;35(4):625-38. Int J Lepr Other Mycobact Dis. 1967. PMID: 4173566 No abstract available.